Posted by Geeta on February 29 2024 at 10:39 AM
public
Castrate-resistant Prostate Cancer Market Overview
Envisaged during the envisaged period, Maximize Market Research envisions a noteworthy upsurge in the market. The scrutiny of the Castrate-resi...
The Castrate Resistant Prostate Cancer Market is estimated to be valued at US$ 11.12 Bn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in ...
Market Overview:Castrate-resistant prostate cancer (CRPC) refers to prostate cancer that continues to grow even after the medical or surgical castration treatment of prostate cancer. It occurs wh...